Frontlight ResearchEarly access
Trial site
London Regional Cancer Centre
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 1/21 trial
- Status
- Completed3 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Ontario Clinical Oncology Group (OCOG)2 trials
- Hoffmann-La Roche1 trial
- Leiden University Medical Center1 trial
- Regeneron Pharmaceuticals1 trial
- SignalChem Lifesciences Corporation1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Active, not recruiting
Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer1 recruiting
- Melanoma1 recruiting
Closed trials
Terminated
Completed
Completed
SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026